Malarvx

Developing innovative malaria vaccines using RNA technology and in vitro culture systems

placeSeattle, Washington, United States calendar_todayFounded 2012 groups5 employees language malarvx.com

Registered entities

Social engagement

Social engagement: 173 social following, 2 posts in the last 12 months — top 10% of its industry.

Investor mix

2 investors on record.

Investor typeCountShare
Other / undisclosed2100%

Recent activity

16 Apr 2026
Event
LSINW26
9 Nov 2025
Event
ASTMH 2025
Coming soon